Cutler Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $265K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $120K | Buy |
|
|||||
|
2022
Q4 | – | Hold |
|
|||||
|
2022
Q3 | – | Hold |
|
|||||
|
2022
Q2 | – | Hold |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.96M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $203K | Buy |
|
|||||
|
2020
Q2 | – | Hold |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $449K | Buy |
|
|||||
|
2019
Q3 | $284K | Sell |
|
|||||
|
2019
Q2 | $394K | Buy |
|
|||||
|
2019
Q1 | $233K | Sell |
|
|||||
|
2018
Q4 | $195K | Sell |
|
|||||
|
2018
Q3 | $252K | Sell |
|
|||||
|
2018
Q2 | $372K | Sell |
|
|||||
|
2018
Q1 | $558K | Sell |
|
|||||
|
2017
Q4 | $5.67M | Buy |
|
|||||
|
2017
Q3 | $5.02M | Buy |
|
|||||
|
2017
Q2 | $2.42M | Buy |
|
|||||
|
2017
Q1 | $1.34M | Buy |
|
|||||
|
2016
Q4 | $727K | Buy |
|
|||||
|
2016
Q3 | $850K | Sell |
|
|||||
|
2016
Q2 | $948K | Buy |
|
|||||
|
2016
Q1 | $285K | Buy |
|
|||||
|
2015
Q4 | $189K | Buy |
|